CA2640127C - Process for the preparation of adamantanamines - Google Patents
Process for the preparation of adamantanamines Download PDFInfo
- Publication number
- CA2640127C CA2640127C CA2640127A CA2640127A CA2640127C CA 2640127 C CA2640127 C CA 2640127C CA 2640127 A CA2640127 A CA 2640127A CA 2640127 A CA2640127 A CA 2640127A CA 2640127 C CA2640127 C CA 2640127C
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- acid
- chlorine
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003477 | 2006-02-21 | ||
| EP06003477A EP1820792B1 (en) | 2006-02-21 | 2006-02-21 | Process for the preparation of adamantanamines |
| PCT/EP2007/001440 WO2007096124A1 (en) | 2006-02-21 | 2007-02-20 | Process for the preparation of adamantanamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2640127A1 CA2640127A1 (en) | 2007-08-30 |
| CA2640127C true CA2640127C (en) | 2015-08-11 |
Family
ID=36754153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2640127A Expired - Fee Related CA2640127C (en) | 2006-02-21 | 2007-02-20 | Process for the preparation of adamantanamines |
Country Status (13)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1908748A1 (en) | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| WO2010007351A1 (en) * | 2008-07-14 | 2010-01-21 | Cipla Limited | Process for the preparation of memantine and its salts and intermediate for use therein |
| CN101560157B (zh) * | 2009-06-02 | 2013-09-18 | 王彦明 | 盐酸金刚烷胺生产工艺及其专用设备 |
| CN102070463A (zh) * | 2009-06-11 | 2011-05-25 | 辽宁利锋科技开发有限公司 | 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用 |
| JP5738854B2 (ja) * | 2009-06-29 | 2015-06-24 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ネラメキサンの製造方法 |
| US8759581B2 (en) | 2009-06-29 | 2014-06-24 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane |
| CA2765609A1 (en) * | 2009-06-29 | 2011-01-06 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
| JP5599878B2 (ja) * | 2009-06-29 | 2014-10-01 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | １−アミノ−１，３，３，５，５−ペンタメチルシクロヘキサンを調製する方法 |
| CN101993377A (zh) * | 2009-08-07 | 2011-03-30 | 出光兴产株式会社 | 具有金刚烷骨架的胺类和季铵盐的制造方法 |
| JP6094837B2 (ja) * | 2013-01-23 | 2017-03-15 | 三菱瓦斯化学株式会社 | メマンチンの製造プロセス |
| CN103483205B (zh) * | 2013-10-12 | 2015-02-04 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN103524353B (zh) * | 2013-10-12 | 2015-03-25 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN104693039B (zh) * | 2015-01-06 | 2016-11-16 | 中山大学 | 一种金刚烷胺类衍生物及其制备方法和应用 |
| CN105399636A (zh) * | 2015-12-18 | 2016-03-16 | 天津民祥生物医药股份有限公司 | 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3391142A (en) | 1966-02-09 | 1968-07-02 | Lilly Co Eli | Adamantyl secondary amines |
| CH603545A5 (US07714131-20100511-C00001.png) * | 1972-04-20 | 1978-08-31 | Merz & Co | |
| DE2318461A1 (de) | 1973-04-12 | 1974-10-31 | Merz & Co | Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen |
| SU805609A1 (ru) * | 1979-10-12 | 1981-09-30 | Предприятие П/Я В-2343 | S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью |
| DE10299048I2 (de) | 1989-04-14 | 2006-07-13 | Merz Pharma Gmbh & Co Kgaa | Verwendung von Adamantan-Derivaten zur Pr{vention und Behandlung der cerebralen Isch{mie |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| CZ288445B6 (en) | 1996-06-20 | 2001-06-13 | Lachema Np | Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane |
| GB0001093D0 (en) | 2000-01-19 | 2000-03-08 | F2 Chemicals Ltd | Selective nitrogen functionalisation of organic compounds |
| GB0018272D0 (en) * | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
| JP4118555B2 (ja) * | 2001-12-13 | 2008-07-16 | 株式会社トクヤマ | Ｎ−（アダマンチル）アミド化合物の製造方法 |
| RU2246482C2 (ru) | 2002-12-25 | 2005-02-20 | ООО "Циклан" | Способ получения гидрохлорида 1-амино-3,5-диметиладамантана |
| CN1240668C (zh) | 2003-09-10 | 2006-02-08 | 上海医药工业研究院 | 一种新的盐酸美金刚制备方法 |
| WO2005062724A2 (en) * | 2003-12-31 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of aminoadamantane derivatives |
| JP2007518755A (ja) * | 2004-01-22 | 2007-07-12 | ノイロサーチ アクティーゼルスカブ | モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物 |
| US7456224B2 (en) * | 2004-04-05 | 2008-11-25 | Forest Laboratories Holdings, Ltd. | Method for treating autism |
| EP1879849A1 (en) * | 2005-05-11 | 2008-01-23 | Dr. Reddy's Laboratories, Inc. | Process for preparing memantine |
-
2006
- 2006-02-21 AT AT06003477T patent/ATE541827T1/de active
- 2006-02-21 PT PT06003477T patent/PT1820792E/pt unknown
- 2006-02-21 EP EP06003477A patent/EP1820792B1/en not_active Not-in-force
- 2006-02-21 SI SI200631279T patent/SI1820792T1/sl unknown
- 2006-02-21 PL PL06003477T patent/PL1820792T3/pl unknown
- 2006-02-21 ES ES06003477T patent/ES2379181T3/es active Active
- 2006-02-21 DK DK06003477.4T patent/DK1820792T3/da active
-
2007
- 2007-02-20 CA CA2640127A patent/CA2640127C/en not_active Expired - Fee Related
- 2007-02-20 WO PCT/EP2007/001440 patent/WO2007096124A1/en active Application Filing
- 2007-02-20 JP JP2008555684A patent/JP5235683B2/ja active Active
- 2007-02-20 US US12/224,147 patent/US20090082596A1/en not_active Abandoned
- 2007-02-20 CN CN2007800060848A patent/CN101389594B/zh not_active Expired - Fee Related
- 2007-02-20 AU AU2007218140A patent/AU2007218140B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT1820792E (pt) | 2012-04-10 |
| JP2009527517A (ja) | 2009-07-30 |
| EP1820792A1 (en) | 2007-08-22 |
| EP1820792B1 (en) | 2012-01-18 |
| AU2007218140A1 (en) | 2007-08-30 |
| AU2007218140B2 (en) | 2010-08-19 |
| US20090082596A1 (en) | 2009-03-26 |
| CA2640127A1 (en) | 2007-08-30 |
| ES2379181T3 (es) | 2012-04-23 |
| DK1820792T3 (da) | 2012-04-10 |
| PL1820792T3 (pl) | 2012-06-29 |
| SI1820792T1 (sl) | 2012-04-30 |
| CN101389594A (zh) | 2009-03-18 |
| JP5235683B2 (ja) | 2013-07-10 |
| CN101389594B (zh) | 2013-06-12 |
| ATE541827T1 (de) | 2012-02-15 |
| WO2007096124A1 (en) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2640127C (en) | Process for the preparation of adamantanamines | |
| US8420858B2 (en) | Process for preparation of iopromide | |
| EP1836157A1 (en) | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride | |
| JP6307087B2 (ja) | ベンズアミド化合物の合成に有用な化合物 | |
| JP2000505820A (ja) | ５―［アセチル（２，３―ジヒドロキシプロピル）アミノ］―ｎ，ｎ′―ビス（２，３―ジヒドロキシプロピル）―２，４，６―トリヨード―１，３―ベンゼンジカルボキシアミドの製造方法 | |
| US8138375B2 (en) | Method for producing 1-formamido-3,5-dimethyladamantane | |
| US20110124899A1 (en) | Method for preparing combretastatin | |
| WO2009057140A2 (en) | Improved process for memantine hydrochloride | |
| US6730809B2 (en) | Processes for the production of α-difluoromethyl ornithine (DFMO) | |
| US9024067B2 (en) | Process for preparing carboxylic acid amides useful in the treatment of muscular disorders | |
| WO2011001976A1 (ja) | スレオ－３－（３，４－ジヒドロキシフェニル）－ｌ－セリンの製造法 | |
| JP4212473B2 (ja) | （ｒ）−または（ｓ）−アミノカルニチン分子内塩、その塩および誘導体の調製方法 | |
| US8754261B2 (en) | Process for the preparation of O-desmethyl-venlafaxine and salts thereof | |
| KR101442716B1 (ko) | 자일릴렌디아민의 제조방법 | |
| JP4356111B2 (ja) | Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法 | |
| JP3150436B2 (ja) | α−（ｍ−ニトロフェニル）アルキルアミンとα−（ｐ−ニトロフェニル）アルキルアミンの分離方法、およびこれを用いたα−（ｍ−アミノフェニル）アルキルアミンおよびα−（ｐ−アミノフェニル）アルキルアミン類の製造方法 | |
| US20140336380A1 (en) | Process for the preparation of agomelatine | |
| JPWO2005121081A1 (ja) | アセトアミドピロリジン誘導体の製造方法およびその中間体化合物 | |
| US20080015383A1 (en) | Process for the preparation of delapril | |
| JP2000128840A (ja) | シス−２−アミノシクロヘキサンカルボン酸およびシス−２−ベンズアミドシクロヘキサンカルボン酸の製造方法 | |
| ITMI20131371A1 (it) | Procedimento per la preparazione di un composto ad attivita' anticonvulsiva |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210222 |